Results
22
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
22 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ADOC | €7.09 | -14.6% | 63.4% | €104.4m | €9.20 | PS17.3x | E59.8% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €18.30 | 2.6% | -28.5% | €151.2m | €30.30 | PE20x | E30.8% | n/a | Capital Goods | ||
VU | €145.00 | 7.4% | 20.6% | €2.3b | €195.12 | PE28.9x | E25.2% | 0.2% | Tech | ||
FDE | €31.55 | 5.2% | -29.6% | €165.0m | €61.33 | PE21x | E31.9% | n/a | Energy | ||
OSE | €6.51 | 6.0% | 80.8% | €141.6m | €10.15 | PS63.6x | E5.9% | n/a | Pharmaceuticals & Biotech | ||
ALMUN | €0.50 | 0% | -80.9% | €4.4m | €1.30 | PB0.4x | E150.0% | n/a | Tech | ||
ALICA | €10.30 | -8.4% | -31.1% | €83.3m | €16.00 | PE15.2x | E26.1% | 1.9% | Tech | ||
ALCUR | €6.10 | 9.3% | 146.0% | €35.2m | €8.48 | PE19.5x | E42.4% | n/a | Capital Goods | ||
MEDCL | €14.76 | 4.5% | 139.2% | €428.9m | €20.70 | PS35.9x | E70.6% | n/a | Pharmaceuticals & Biotech | ||
ALSMA | €3.68 | -2.6% | 49.6% | €19.2m | €5.80 | PE18.1x | E35.2% | n/a | Healthcare | ||
ALLIX | €8.76 | -2.7% | -25.4% | €57.0m | €16.00 | PS1.7x | E101.6% | n/a | Software | ||
S30 | €1.60 | 4.6% | -42.4% | €171.4m | €2.75 | PB1.6x | E102.6% | n/a | Software | ||
CLA | €1.94 | 9.4% | 8.4% | €110.1m | €4.75 | PE-22x | E90.6% | n/a | Software | ||
ALECP | €0.36 | 5.6% | -28.3% | €44.3m | n/a | PE49.2x | E86.8% | 0% | Media | ||
ALCIS | €8.46 | -0.5% | -14.7% | €65.9m | €12.10 | PE20.7x | E56.2% | 1.9% | Commercial Services | ||
ATEME | €4.20 | 1.0% | -55.5% | €48.3m | €11.00 | PB1.3x | E91.5% | n/a | Tech | ||
ALHOP | €20.90 | -3.7% | 15.5% | €60.0m | €30.05 | PE13.1x | E21.5% | 3.1% | Media | ||
LSS | €30.15 | 6.2% | 11.0% | €1.1b | €35.70 | PE34.1x | E28.6% | 1.2% | Software | ||
OVH | €5.97 | 0.7% | -35.4% | €1.1b | €9.90 | PS1.2x | E103.7% | n/a | Software | ||
ALLPL | €0.76 | 0% | -67.8% | €9.2m | €1.00 | PB6.5x | E97.3% | n/a | Consumer Services | ||
ALPAT | €14.00 | 2.9% | 9.4% | €15.4m | €11.50 | n/a | E92.7% | n/a | Pharmaceuticals & Biotech | ||
EXN | €21.85 | 9.8% | 14.0% | €2.0b | €24.39 | PE45.9x | E28.4% | 0% | Software |